756 related articles for article (PubMed ID: 16432520)
1. A versatile tool for conditional gene expression and knockdown.
Szulc J; Wiznerowicz M; Sauvain MO; Trono D; Aebischer P
Nat Methods; 2006 Feb; 3(2):109-16. PubMed ID: 16432520
[TBL] [Abstract][Full Text] [Related]
2. Conditional gene expression and knockdown using lentivirus vectors encoding shRNA.
Szulc J; Aebischer P
Methods Mol Biol; 2008; 434():291-309. PubMed ID: 18470652
[TBL] [Abstract][Full Text] [Related]
3. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
4. Stable suppression of gene expression in murine embryonic stem cells by RNAi directed from DNA vector-based short hairpin RNA.
Tang FC; Meng GL; Yang HB; Li CJ; Shi Y; Ding MX; Shang KG; Zhang B; Xue YF
Stem Cells; 2004; 22(1):93-9. PubMed ID: 14688395
[TBL] [Abstract][Full Text] [Related]
5. Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo.
Centlivre M; Zhou X; Pouw SM; Weijer K; Kleibeuker W; Das AT; Blom B; Seppen J; Berkhout B; Legrand N
Gene Ther; 2010 Jan; 17(1):14-25. PubMed ID: 19727135
[TBL] [Abstract][Full Text] [Related]
6. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy.
Capowski EE; Schneider BL; Ebert AD; Seehus CR; Szulc J; Zufferey R; Aebischer P; Svendsen CN
J Neurosci Methods; 2007 Jul; 163(2):338-49. PubMed ID: 17397931
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific RNA interference using lentiviral vectors.
Nielsen TT; Marion Iv; Hasholt L; Lundberg C
J Gene Med; 2009 Jul; 11(7):559-69. PubMed ID: 19434604
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral vectors: regulated gene expression.
Kafri T; van Praag H; Gage FH; Verma IM
Mol Ther; 2000 Jun; 1(6):516-21. PubMed ID: 10933976
[TBL] [Abstract][Full Text] [Related]
10. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
Mitta B; Weber CC; Rimann M; Fussenegger M
Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
[TBL] [Abstract][Full Text] [Related]
11. Inducible gene and shRNA expression in resident hematopoietic stem cells in vivo.
Laurenti E; Barde I; Verp S; Offner S; Wilson A; Quenneville S; Wiznerowicz M; Macdonald HR; Trono D; Trumpp A
Stem Cells; 2010 Aug; 28(8):1390-8. PubMed ID: 20641037
[TBL] [Abstract][Full Text] [Related]
12. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
[TBL] [Abstract][Full Text] [Related]
13. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
[TBL] [Abstract][Full Text] [Related]
14. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors.
Ma Y; Ramezani A; Lewis R; Hawley RG; Thomson JA
Stem Cells; 2003; 21(1):111-7. PubMed ID: 12529558
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
[TBL] [Abstract][Full Text] [Related]
16. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
17. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
[TBL] [Abstract][Full Text] [Related]
18. Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi.
Sapru MK; Yates JW; Hogan S; Jiang L; Halter J; Bohn MC
Exp Neurol; 2006 Apr; 198(2):382-90. PubMed ID: 16455076
[TBL] [Abstract][Full Text] [Related]
19. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.
Rubinson DA; Dillon CP; Kwiatkowski AV; Sievers C; Yang L; Kopinja J; Rooney DL; Zhang M; Ihrig MM; McManus MT; Gertler FB; Scott ML; Van Parijs L
Nat Genet; 2003 Mar; 33(3):401-6. PubMed ID: 12590264
[TBL] [Abstract][Full Text] [Related]
20. Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system.
Palais G; Nguyen Dinh Cat A; Friedman H; Panek-Huet N; Millet A; Tronche F; Gellen B; Mercadier JJ; Peterson A; Jaisser F
Physiol Genomics; 2009 Apr; 37(2):140-6. PubMed ID: 19141541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
